Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q4 2015 13F Holders as of 31 Dec 2015
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 33,010,570
- Share change
- +1,515,122
- Total reported value
- $2,143,167,128
- Put/Call ratio
- 45%
- Price per share
- $64.92
- Number of holders
- 141
- Value change
- +$96,156,802
- Number of buys
- 73
- Number of sells
- 65
Report period
Q4 2015
Institutions
141
Top holders
10
AGIO full security history
Newer quarter: Q1 2016
Previous quarter: Q3 2015
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9.5%
|
5,616,553
|
$396,472,000 | — | 30 Sep 2015 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.4%
|
4,977,114
|
$351,335,000 | — | 30 Sep 2015 | |
| Capital World Investors |
13F
|
Company |
5.1%
|
3,031,120
|
$213,967,000 | — | 30 Sep 2015 | |
| BB BIOTECH AG |
13F
|
Company |
3.6%
|
2,109,921
|
$148,939,000 | — | 30 Sep 2015 | |
| Flagship Ventures 2007 General Partner LLC |
13F
|
Company |
3.2%
|
1,930,369
|
$136,265,000 | — | 30 Sep 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,806,818
|
$127,544,000 | — | 30 Sep 2015 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
2.7%
|
1,623,430
|
$114,598,000 | — | 30 Sep 2015 | |
| Capital International Investors |
13F
|
Company |
2.3%
|
1,345,172
|
$94,956,000 | — | 30 Sep 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.3%
|
766,783
|
$54,127,000 | — | 30 Sep 2015 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1%
|
611,653
|
$43,177,000 | — | 30 Sep 2015 | |
| STATE STREET CORP |
13F
|
Company |
0.98%
|
582,347
|
$41,105,000 | — | 30 Sep 2015 | |
| CAPITAL GUARDIAN TRUST CO |
13F
|
Company |
0.7%
|
414,790
|
$29,280,000 | — | 30 Sep 2015 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.69%
|
411,653
|
$29,059,000 | — | 30 Sep 2015 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
0.66%
|
392,133
|
$27,681,000 | — | 30 Sep 2015 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.55%
|
325,434
|
$22,972,000 | — | 30 Sep 2015 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.53%
|
314,878
|
$22,227,000 | — | 30 Sep 2015 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.43%
|
253,457
|
$17,892,000 | — | 30 Sep 2015 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
244,900
|
$17,287,000 | — | 30 Sep 2015 | |
| Apex Capital Management |
13F
|
Company |
0.38%
|
228,601
|
$16,137,000 | — | 30 Sep 2015 | |
| Artal Group S.A. |
13F
|
Company |
0.38%
|
225,000
|
$15,883,000 | — | 30 Sep 2015 | |
| Cannell & Co. |
13F
|
Company |
0.37%
|
218,855
|
$15,449,000 | — | 30 Sep 2015 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.34%
|
204,814
|
$14,458,000 | — | 30 Sep 2015 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.29%
|
174,286
|
$12,303,000 | — | 30 Sep 2015 | |
| NORGES BANK |
13F
|
Company |
0.28%
|
169,049
|
$11,934,000 | — | 30 Sep 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
163,634
|
$11,550,000 | — | 30 Sep 2015 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.27%
|
158,943
|
$11,220,000 | — | 30 Sep 2015 | |
| CAPITAL INTERNATIONAL LTD /CA/ |
13F
|
Company |
0.25%
|
147,200
|
$10,391,000 | — | 30 Sep 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
140,640
|
$9,928,000 | — | 30 Sep 2015 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.21%
|
126,161
|
$8,906,000 | — | 30 Sep 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
119,569
|
$8,441,000 | — | 30 Sep 2015 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
109,521
|
$7,731,000 | — | 30 Sep 2015 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.18%
|
104,505
|
$7,377,000 | — | 30 Sep 2015 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
103,057
|
$7,275,000 | — | 30 Sep 2015 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.17%
|
101,299
|
$7,151,000 | — | 30 Sep 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.17%
|
100,000
|
$7,059,000 | — | 30 Sep 2015 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
0.16%
|
95,243
|
$6,723,000 | — | 30 Sep 2015 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.15%
|
86,435
|
$6,101,000 | — | 30 Sep 2015 | |
| Capital International Sarl |
13F
|
Company |
0.14%
|
81,300
|
$5,739,000 | — | 30 Sep 2015 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.13%
|
76,880
|
$5,427,000 | — | 30 Sep 2015 | |
| AXA S.A. |
13F
|
Company |
0.12%
|
73,379
|
$5,180,000 | — | 30 Sep 2015 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.12%
|
72,700
|
$5,132,000 | — | 30 Sep 2015 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.11%
|
66,606
|
$4,702,000 | — | 30 Sep 2015 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.09%
|
54,880
|
$3,874,000 | — | 30 Sep 2015 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
54,601
|
$3,854,000 | — | 30 Sep 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
54,150
|
$3,819,000 | — | 30 Sep 2015 | |
| Bellevue Asset Management AG |
13F
|
Company |
0.09%
|
54,000
|
$3,812,000 | — | 30 Sep 2015 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.09%
|
51,500
|
$3,635,000 | — | 30 Sep 2015 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.09%
|
51,444
|
$3,631,000 | — | 30 Sep 2015 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
50,289
|
$3,550,000 | — | 30 Sep 2015 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
50,137
|
$3,538,000 | — | 30 Sep 2015 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2015
As of 31 Dec 2015,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,010,570 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, BB BIOTECH AG, Flagship Ventures 2007 General Partner LLC, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, Capital International Investors, Clearbridge Investments, LLC, and STATE STREET CORP.
This page lists
141
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2015 vs Q3 2015 Across Filers
Q3 2015 holders
149
Q4 2015 holders
141
Holder diff
-8
| Investor | Q3 2015 Shares | Q4 2015 Shares | Share Diff | Share Chg % | Q3 2015 Value $ | Q4 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.